This invention relates to a drug delivery device, comprising a piston and a drug reservoir for comprising a drug and a piston. The drug reservoir comprises a flexible wall, and a dispensing hole for dispensing the drug into an environment of the drug delivery device. The piston is arranged for pressing against the flexible wall to compress the drug reservoir for pushing an amount of the drug through the dispensing hole.
Such a drug delivery device may comprise a small sized electrical motor, e.g. stepper motor, of which the action is controlled by an on-board microprocessor. The stepper motor moves the piston forward against the wall, e.g. pushed by a screw rod mechanism. The piston is moved in a controlled way as far as speed and stroke are considered. The piston pushes the flexible wall into the drug reservoir. As a result, the volume of the drug reservoir decreases and the pressure inside the drug reservoir increases. The increasing pressure causes an amount of the drug to be pushed out of the dispensing hole. While the piston pushes the flexible wall into the drug reservoir, it takes a shape that corresponds to minimum surface energy. Such shapes usually are irregular, resulting in a smaller usable drug reservoir volume and a higher resistance for the piston to move forward. When the drug reservoir becomes emptier, the flexible wall starts to fold until the piston can no longer overcome resistance from the folds and the drug viscosity and stops dispensing. When the piston stops dispensing, drugs stay behind in the folds. Consequently, it is not possible to fully empty the drug reservoir. Additionally, there is a problem of the piston sliding along the folded flexible wall surface without causing any drug to be pushed out of the dispensing hole because the piston mechanism cannot be effective.
It is an object of the invention to provide a drug delivery device as described above, wherein the drug reservoir can be emptied more reliably.
According to a first aspect of the invention, this object is achieved by providing a drug delivery device, comprising a drug reservoir, a piston and an adhesion interface. The drug reservoir comprises a flexible wall and a dispensing hole for dispensing the drug into an environment of the drug delivery device. The piston is arranged for pressing against the flexible wall to compress the drug reservoir for pushing an amount of the drug through the dispensing hole. The adhesion interface is situated between a surface of the piston and the flexible wall for preventing sliding between the surface of the piston and the flexible wall.
The adhesion interface keeps the flexible wall surface conformed to the piston surface and prevents both surfaces from slipping between each other. With every step of the piston into the flexible wall and in the direction of the delivery hole, a greater part of its surface gets covered by and adheres to the flexible wall surface. The flexible wall surface does not fold, but is slid around the piston surface.
The adhesion interface may, e.g., be a sticky coating on the piston surface and/or on the flexible wall. Alternatively, a magnetic coating is used on at least one of the two surfaces for providing the required adhesion.
In a preferred embodiment, the flexible wall comprises at least one non-flexible part located at the adhesion interface. An advantage of a non-flexible part is that it cannot be folded or wrinkled. When the piston pushes against a non-flexible part, its shape does not change. The flexible parts of the flexible wall meanwhile ensure that the flexible wall as a whole is still deformable and can be used for compressing the drug reservoir.
In a flexible wall with only one or a few non-flexible parts, the surface of the non-flexible parts preferably follows the contours of the piston surface at the contact area of both surfaces. This ensures an optimal distribution of the pressure exerted by the piston upon the flexible wall and further facilitates the emptying of the reservoir. In addition, the preformed flexible wall makes it easier to fill the reservoir to the right dose without the piston already placed against the flexible wall.
These and other aspects of the invention are apparent from and will be elucidated with reference to the embodiments described hereinafter.
In the drawings:
The actuation mechanism 11, 12 comprises a piston 11 and a small sized electrical motor, e.g. a stepper motor 12, for pushing the piston by means of a screw rod mechanism towards the drug reservoir 10. Instead of a stepper motor 12, different driving means may be used for driving the piston 12. The driving of the piston 11 may, e.g., be realized using (electro-)magnetic forces or a swelling agent. When the piston 11 is pressed against the medicine reservoir 10, the medicine reservoir is compressed and the pressure inside the medicine reservoir 10 increases. As a result of the increasing pressure, the drug is pushed out of the drug delivery device 50 through a dispensing hole 15. The drug release may, e.g., be triggered by an internal clock, sensor values from a pH-sensor or trigger signals from an electrical or chemical detector element. If the drug delivery device 50 comprises means for wireless communication, the drug delivery may be externally triggered. The operations of all electronic functions of the device 50 are controlled by a microprocessor 17 and powered by a battery 16.
The adhesion surface 51 may be a sticky surface applied to the piston 11 and/or flexible wall 22 surface. Alternatively, a magnetic coating may cover one of the surfaces, while the other surface is either magnetic or magnetizable. Another option is to use electrostatic interaction using an electrostatically charged polymer. A skilled person will be able to come up with many other possible ways of providing a suitable adhesion surface 51. The adhesion surface 51 used is preferably such that the drug reservoir 10 can still be removed from the adhered piston 11 surface for enabling refilling of the drug reservoir 10 without damaging the piston 11 or the drug reservoir. It is preferable that also the adhesion layer 51 keeps intact when the drug reservoir 10 and the piston 11 are separated. Alternatively, the drug reservoir 10 and/or the adhesion layer 51 are replaced when preparing the drug delivery device 50 for a second use.
Such an adhesion layer 51, which makes it possible to separate the surfaces without damaging the piston 11 or the reservoir 10, also enables a further option. When the reservoir 10 is completely or partly compressed and the piston 11 movement is reversed, the pressure inside the reservoir 10 will drop and body fluid will be sucked into the reservoir 10.
The non-flexible part 61 ensures an optimal distribution of the pressure exerted by the piston 11 upon the flexible wall 22 and further facilitates the emptying of the reservoir 10. In addition, the preformed flexible wall 22 makes it easier to fill the reservoir to the right dose without the piston 11 already placed against the flexible wall 22. If a fully flexible drug reservoir 10 would be filled to the rim, the viscosity of the drug may result in too much resistance for the piston to start moving.
It should be noted that the above-mentioned embodiments illustrate rather than limit the invention, and that those skilled in the art will be able to design many alternative embodiments without departing from the scope of the appended claims. In the claims, any reference signs placed between parentheses shall not be construed as limiting the claim. Use of the verb “comprise” and its conjugations does not exclude the presence of elements or steps other than those stated in a claim. The article “a” or “an” preceding an element does not exclude the presence of a plurality of such elements. The invention may be implemented by means of hardware comprising several distinct elements, and by means of a suitably programmed computer. In the device claim enumerating several means, several of these means may be embodied by one and the same item of hardware. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB2010/053610 | 8/10/2010 | WO | 00 | 2/7/2013 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2011/018753 | 2/17/2011 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4102998 | Gutnick | Jul 1978 | A |
4236516 | Nilson | Dec 1980 | A |
4457752 | Vadasz | Jul 1984 | A |
4564363 | Bagnall et al. | Jan 1986 | A |
4572403 | Benaroya | Feb 1986 | A |
4814180 | Eckenhoff et al. | Mar 1989 | A |
5071040 | Laptewicz, Jr. | Dec 1991 | A |
5170801 | Casper et al. | Dec 1992 | A |
5279607 | Schentag et al. | Jan 1994 | A |
5318557 | Gross | Jun 1994 | A |
5423779 | Yeh | Jun 1995 | A |
5567592 | Benet et al. | Oct 1996 | A |
5728396 | Peery et al. | Mar 1998 | A |
5853386 | Davis et al. | Dec 1998 | A |
6053899 | Slanda et al. | Apr 2000 | A |
6182941 | Scheurenbrand et al. | Feb 2001 | B1 |
6423779 | Sue et al. | Jul 2002 | B2 |
6485471 | Zivitz et al. | Nov 2002 | B1 |
6632216 | Houzego et al. | Oct 2003 | B2 |
6699214 | Gellman | Mar 2004 | B2 |
6776165 | Jin | Aug 2004 | B2 |
6800060 | Marshall | Oct 2004 | B2 |
6803373 | Schellens | Oct 2004 | B2 |
6929636 | von Alten | Aug 2005 | B1 |
7014640 | Kemppainen et al. | Mar 2006 | B2 |
7030132 | Schellens et al. | Apr 2006 | B2 |
8021357 | Tanaka et al. | Sep 2011 | B2 |
8100889 | Kawano et al. | Jan 2012 | B2 |
8308681 | Slocum et al. | Nov 2012 | B2 |
20020072735 | Kupperblatt et al. | Jun 2002 | A1 |
20030020810 | Takizawa et al. | Jan 2003 | A1 |
20030213495 | Fujita et al. | Nov 2003 | A1 |
20040242962 | Uchiyama | Dec 2004 | A1 |
20040267240 | Gross et al. | Dec 2004 | A1 |
20040267241 | Russell | Dec 2004 | A1 |
20050147559 | von Alten | Jul 2005 | A1 |
20050222537 | Dinsmoor et al. | Oct 2005 | A1 |
20060145876 | Kimura et al. | Jul 2006 | A1 |
20060155174 | Glukhovsky et al. | Jul 2006 | A1 |
20070138027 | Dinsmoor et al. | Jun 2007 | A1 |
20070213659 | Trovato et al. | Sep 2007 | A1 |
20100280464 | De Graaff et al. | Nov 2010 | A1 |
Number | Date | Country |
---|---|---|
1958090 | May 2007 | CN |
3339323 | May 1985 | DE |
2794654 | Dec 2000 | FR |
2001526939 | Dec 2001 | JP |
2002532162 | Oct 2002 | JP |
2003520108 | Jul 2003 | JP |
2005511184 | Apr 2005 | JP |
2005536307 | Dec 2005 | JP |
WO03008637 | Jan 2003 | WO |
WO03068061 | Aug 2003 | WO |
WO2005025647 | Mar 2005 | WO |
WO2005038049 | Apr 2005 | WO |
WO2006021932 | Mar 2006 | WO |
WO2006025013 | Mar 2006 | WO |
WO2006044049 | Apr 2006 | WO |
WO2006056944 | Jun 2006 | WO |
WO2006077527 | Jul 2006 | WO |
WO2006077529 | Jul 2006 | WO |
WO2008029372 | Mar 2008 | WO |
WO2008038199 | Apr 2008 | WO |
WO2008062335 | May 2008 | WO |
WO 2008062335 | May 2008 | WO |
WO2010086681 | Aug 2010 | WO |
Entry |
---|
The Chinese Office Action dated Sep. 6, 2013 for Chinese patent application No. 201080040663.6, a counterpart foreign application of U.S. Appl. No. 13/390,111, 4 pages. |
The Chinese Office Action dated Jan. 15, 2013 for Chinese patent application No. 201080015953.5, a counterpart foreign application of U.S. Appl. No. 13/262,841, 17 pages. |
The Chinese Office Action dated Jan. 21, 2013 for Chinese patent application No. 201080040663.6, a counterpart foreign application of U.S. Appl. No. 13/390,111, 8 pages. |
The Chinese Office Action dated Mar. 14, 2013 for Chinese patent application No. 200980112018.8, a counterpart foreign application of U.S. Appl. No. 12/933,891, 12 pages. |
The Chinese Office Action dated May 13, 2013 for Chinese patent application No. 201080015284.1, a counterpart foreign application of U.S. Appl. No. 13/262,861, 11 pages. |
The Chinese Office Action dated Aug. 5, 2013 for Chinese patent application No. 201080015953.5, a counterpart foreign application of U.S. Appl. No. 13/262,841, 7 pages. |
The European Office Action dated Jul. 25, 2013 for European patent application No. 10779040.4, a counterpart foreign application of U.S. Appl. No. 13/498,835, 4 pages. |
Evans, et al., “Measurement of Gastrointestinal pH Profiles in Normal Ambulant Human Subjects”, GUT, vol. 29, 1988, pp. 1035-1041. |
Hindmarsh et al., “Height Monitoring as a diagnostic test”, at www.archdischild.com, Arch Dis Child, 2004, 2 pages. |
The Japanese Office Action dated Apr. 16, 2013 for Japanese Patent Applicaiton No. 2011-514179, a counterpart foreign application of U.S. Appl. No. 12/992,305, 9 pages. |
The Japanese Office Action dated Apr. 23, 2013 for Japanese patent application No. 2012-524322, a counterpart foreign application of U.S. Appl. No. 13/390,111, 6 pages. |
The Japanese Office Action dated Apr. 30, 2013 for Japanese patent application No. 2010-546431, a counterpart foreign application of U.S. Appl. No. 12/867,888, 4 pages. |
The Japanese Office Action dated Jun. 25, 2013 for Japanese patent application No. 2012531527, a counterpart foreign application of U.S. Appl. No. 13/498,835, 8 pages. |
Kompella, et al., “Delivery System for Penetration Enhancement of Peptide and Protein Drugs: Design Considerations”, Advanced Drug Delivery Reviews, vol. 46, 2001, pp. 211-245. |
Office action for U.S. Appl. No. 12/992,305, dated Jul. 16, 2013, Zou et al., “Device for Delivery of Powder Like Medication in a Humid Environment”, 14 pages. |
Non-Final Office Action for U.S. Appl. No. 11/720,242, dated Jul. 3, 2013, Gerardus Rudolph Langereis et al., “Electronically Controlled Pill and System Having at Least One Sensor for Delivering at Least One Medicament”, 22 pages. |
Office action for U.S. Appl. No. 13/262,861, dated Aug. 2, 2013, Shimizu et al., “Valveless Drug Delivery Device”, 8 pages. |
Office action for U.S. Appl. No. 12/867,888, dated Sep. 11, 2013,Shimizu, “Administration of Drugs to a Patient”, 11 pages. |
Paine, et al., “Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism”, The Journal of Pharmacology and Experimental Therapeutics, vol. 283, No. 3, 1997, pp. 1552-1562. |
Siccardi, et al., “Regulation of Intestinal Epithelial Function: A Link Between Opportunities for Macromolecular Drug Delivery and Inflammatory Bowel Disease”, Advanced Drug Delivery Reviews, vol. 57, 2005, pp. 219-235. |
Number | Date | Country | |
---|---|---|---|
20130204233 A1 | Aug 2013 | US |
Number | Date | Country | |
---|---|---|---|
61233187 | Aug 2009 | US |